These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 23046209)
1. Octreotide for the treatment of sulfonylurea poisoning. Glatstein M; Scolnik D; Bentur Y Clin Toxicol (Phila); 2012 Nov; 50(9):795-804. PubMed ID: 23046209 [TBL] [Abstract][Full Text] [Related]
2. Octreotide's role in the management of sulfonylurea-induced hypoglycemia. Dougherty PP; Klein-Schwartz W J Med Toxicol; 2010 Jun; 6(2):199-206. PubMed ID: 20352540 [TBL] [Abstract][Full Text] [Related]
3. Octreotide for sulfonylurea-induced hypoglycemia following overdose. Carr R; Zed PJ Ann Pharmacother; 2002 Nov; 36(11):1727-32. PubMed ID: 12398568 [TBL] [Abstract][Full Text] [Related]
4. Octreotide: an antidote for sulfonylurea-induced hypoglycemia. McLaughlin SA; Crandall CS; McKinney PE Ann Emerg Med; 2000 Aug; 36(2):133-138. PubMed ID: 10918104 [TBL] [Abstract][Full Text] [Related]
5. Safety of subcutaneous octreotide in patients with sulfonylurea-induced hypoglycemia and congestive heart failure. Vallurupalli S Ann Pharmacother; 2010 Feb; 44(2):387-90. PubMed ID: 20118140 [TBL] [Abstract][Full Text] [Related]
6. The effectiveness of various doses of octreotide for sulfonylurea-induced hypoglycemia after overdose. Gul M; Cander B; Girisgin S; Ayan M; Kocak S; Unlu A Adv Ther; 2006; 23(6):878-84. PubMed ID: 17276956 [TBL] [Abstract][Full Text] [Related]
7. [Successful treatment of severe sulfonylurea-induced hypoglycemia by the subcutaneous administration of octreotide in an elderly patient with diabetes: A case report]. Nakaya M; Oka R; Miyamoto S Nihon Ronen Igakkai Zasshi; 2019; 56(3):336-342. PubMed ID: 31366755 [TBL] [Abstract][Full Text] [Related]
9. Successful treatment of sulfonylurea-induced prolonged hypoglycemia with use of octreotide. Fleseriu M; Skugor M; Chinnappa P; Siraj ES Endocr Pract; 2006; 12(6):635-40. PubMed ID: 17229659 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of the use and safety of octreotide as antidotal therapy for sulfonylurea overdose in children. Dougherty PP; Lee SC; Lung D; Klein-Schwartz W Pediatr Emerg Care; 2013 Mar; 29(3):292-5. PubMed ID: 23426239 [TBL] [Abstract][Full Text] [Related]
15. Octreotide for hypoglycemia caused by sulfonylurea and DPP-4 inhibitor. Yamaguchi S; Ikejima M; Furukawa A; Abe M; Nakazaki M; Ishihara H Diabetes Res Clin Pract; 2015 Aug; 109(2):e8-e10. PubMed ID: 26025695 [TBL] [Abstract][Full Text] [Related]
16. Continuous octreotide infusion for sulfonylurea-induced hypoglycemia in a toddler. Llamado R; Czaja A; Stence N; Davidson J J Emerg Med; 2013 Dec; 45(6):e209-13. PubMed ID: 23827165 [TBL] [Abstract][Full Text] [Related]
17. Comparison of octreotide and standard therapy versus standard therapy alone for the treatment of sulfonylurea-induced hypoglycemia. Fasano CJ; O'Malley G; Dominici P; Aguilera E; Latta DR Ann Emerg Med; 2008 Apr; 51(4):400-6. PubMed ID: 17764782 [TBL] [Abstract][Full Text] [Related]
18. [Role of octreotide in the treatment of hypoglycemia induced by sulfonylureas]. Clerc D; Hugli O; Trueb L; Yersin B Rev Med Suisse; 2008 Aug; 4(167):1764-7. PubMed ID: 18800755 [TBL] [Abstract][Full Text] [Related]
20. Effectiveness of octreotide in a case of refractory sulfonylurea-induced hypoglycemia. Green RS; Palatnick W J Emerg Med; 2003 Oct; 25(3):283-7. PubMed ID: 14585456 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]